Noubar Afeyan

Johnson & Johnson CEO Joaquin Duato says the company has no plans to enter the obesity market, instead focusing on areas such as cancer. He says oncology remains one of J&J's core growth pillars, and highlights dementia as another major challenge for the healthcare industry. Duat ...  Show more

David Booth started Dimensional Fund Advisors out of a Brooklyn brownstone in 1981 with an idea that challenged conventional investing: investors should have exposure to smaller companies as part of a diversified portfolio. Today, Dimensional manages more than $1 trillion. Booth ...  Show more

In the field of bio-tech, it can take 10 years and millions of dollars to see if an experimental idea might turn into a life-saving treatment—if it ever does. Noubar Afeyan fully understood those risks when he co-founded Moderna in 2010. He and his colleagues were looking for a w ...  Show more

Moderna CEO Stephane Bancel talks about the Moderna vaccine, drug prices, and future of the company with Bloomberg's Paul Sweeny and Matt Miller. See omnystudio.com/listener for privacy information. 

Moderna’s CEO Stéphane Bancel will go down in history for pioneering the Covid-19 vaccine. He sits down with Bob to recount the story of the pandemic from his perspective, from the moment he knew it would become an international disaster to the decision to throw out Moderna’s pla ...  Show more

It has been a busy few days for the United States as the pandemic-related news has been fast and furious. Pfizer reported better-than-expected profits and a lot of its revenue has come from the COVID-19 vaccine. Maxx Chatsko joins Dan Kline to talk about that, President Joe Bi ...